Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MP0250 in advanced solid tumors
NCT02194426Phase 2Completed
- Sponsor
- Molecular Partners AG
- Start
- Jul 2014
- Primary completion
- Feb 2018
- Countries
- 3
01
Overview
A Phase 2 trial of MP-0250 in solid tumor (advanced stage), sponsored by Molecular Partners AG. Started Jul 2014; status: completed.
02
Drugs
MP-0250
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT02194426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02194426.